AKTX vs LULU · $17.2M cap vs P/E 17, rev $11.10B
Akari Therapeutics PLC (AKTX) versus Lululemon Athletica Inc. (LULU) — a side-by-side from cached financials, not a winner call.
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
Lululemon Athletica Inc. (LULU) is a apparel retail company listed on US. It is led by Calvin McDonald.
AKTX does not have a complete income-statement cache yet.
Latest reported LULU revenue for 2026-02-01 was $11.10B. Net income was $1.58B. Revenue was up 4.9% from 2025-02-02 to 2026-02-01. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
AKTX currently screens at market cap $17.2M. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
Not investment advice. Open the AKTX and LULU stock pages for the full models.
Not investment advice.